Logo-bi
Original Research

1. In vitro study of the anticancer activity of various doxorubicin-containing dispersions
Tatiana Matvienko, Viktoriya Sokolova, Svitlana Prylutska, Yuliia Harahuts, Nataliya Kutsevol, Viktor Kostjukov, Maxim Evstigneev* ORCID, Yuriy Prylutskyy*, Matthias Epple, Uwe Ritter
Bioimpacts. 2019;9(1): 57-63. doi: 10.15171/bi.2019.07
PMCID: PMC6378100     PMID: 30788260     Scopus ID: 85060451771    
Article
PDF
Full Text
XML
Cited By:
18
2
14
It was found that the Dextran-PNIPAM+Dox nanofluid in contrast to Dox alone showed higher toxicity towards HeLa cells, whereas the SWCNT+Dox and GO+Dox nanofluids protected cells from Dox.
Original Research

2. Mode of photoexcited C60 fullerene involvement in potentiating cisplatin toxicity against drug-resistant L1210 cells
Daria Franskevych ORCID, Svitlana Prylutska* ORCID, Iryna Grynyuk ORCID, Ganna Pasichnyk ORCID, Liudmyla Drobot ORCID, Olga Matyshevska ORCID, Uwe Ritter ORCID
Bioimpacts. 2019;9(4): 211-217. doi: 10.15171/bi.2019.26
PMCID: PMC6879712     PMID: 31799157     Scopus ID: 85077126162    
Article
PDF
Full Text
XML
Cited By:
2
2
2
Synergic cytotoxic activity of photoexcited C60 fullerene and cisplatin in a low concentration against leukemic L1210 cells resistant to cisplatin was established. The activation of p38 MAP kinase, decrease of mitochondrial membrane potential and L1210R cells accumulation in subG1 phase were found.

As a peer-reviewed international open-access journal, BioImpacts publishes articles on basic and translational aspects of pharmaceutical and biomedical sciences. 
Acceptance rate: 24% 
Publication fee: Free of charge